Immune hemolytic anemia caused by drugs
- 16 April 2012
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Safety
- Vol. 11 (4) , 635-642
Abstract
Introduction: Drug-induced immune hemolytic anemia (DIIHA) is a rare cytopenia; about 130 drugs have been incriminated. The antibodies causing DIIHA can be i) drug-independent (drug not needed to be present to detect antibodies in vitro)—DIIHA caused by this type of antibody presents clinically and serologically as an autoimmune hemolytic anemia (AIHA) with red cell (RBC) autoantibodies in patients' sera and in eluates from their RBCs; or (2) drug-dependent (antibodies react in vitro with RBCs only in the presence of drug, on the RBC membrane or when added to the patient's plasma and RBCs). Areas covered: Literature is reviewed regarding pathophysiology of DIIHA (mechanisms; incidence of drugs involved; the clinical, hematological, and serological characteristics of the most common antibodies causing DIIHA). Expert opinion: DIIHA is often poorly investigated and many reports do not provide data to support the diagnosis (i.e., no serology to support an immune etiology). The three most common drugs currently causing DIIHA are piperacillin, cefotetan, and ceftriaxone. All three (especially piperacillin) can cause in vitro and in vivo effects mimicking AIHA, and in transfused patients, hemolytic transfusion reactions. It is important to exclude DIIHA in such patients as the only treatment needed is to discontinue the drug.Keywords
This publication has 44 references indexed in Scilit:
- Profound piperacillin‐mediated drug‐induced immune hemolysis in a patient with cystic fibrosisTransfusion, 2011
- Serologic characteristics of ceftriaxone antibodies in 25 patients with drug‐induced immune hemolytic anemia (CME)Transfusion, 2011
- Immune hemolytic anemia due to cimetidine: the first example of a cimetidine antibodyTransfusion, 2010
- Tissue oversight in hospitals: the role of the transfusion servicesTransfusion, 2007
- Developing phage display tools for use in transfusion medicineTransfusion, 2005
- Direct oral questions to blood donors: the impact on screening for human immunodeficiency virusTransfusion, 1994
- Fatal immune hemolytic anemia due to cefotetanTransfusion, 1992
- Severe immune‐mediated hemolytic anemia secondary to treatment with cefotetanTransfusion, 1992
- A fatal case of ceftriaxone (Rocephin)‐induced hemolytic anemia associated with intravascular immune hemolysisTransfusion, 1991
- ‘Immune complex’ mediated intravascular hemolysis due to IgM cephalosporin‐dependent antibodyTransfusion, 1987